Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Shareholders held by UnitedHealth Group Incorporated on June 1, 2026. The filing details the voting results for director elections, executive compensation, auditor ratification, and a shareholder proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Shareholders representing 768,066,717 shares voted on four matters:
- Election of Directors: All nine nominees were elected with support ranging from 89.68% to 98.96% of votes cast.
- Executive Compensation: The non-binding advisory vote was approved with 82.74% of votes cast in favor.
- Auditor Ratification: The appointment of Deloitte & Touche LLP was ratified with 95.00% of votes cast in favor.
- Shareholder Proposal: A proposal requiring an independent board chair was not approved, receiving only 20.24% of votes cast.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific vote counts for the director receiving the lowest support (Charles Baker at 89.68%) to assess potential governance concerns.
- Review the full text of the rejected shareholder proposal regarding the independent board chair to understand the rationale behind the 20.24% support level.
- Confirm the total number of shares represented at the meeting (768,066,717) against the company's total outstanding shares to calculate participation rates.